Skip to Content
Merck
All Photos(1)

Documents

CLS431751

Corning® cell strainer

pore size 70 μm, white, sterile, pkg of (individually wrapped), pack of 50 ea, Corning 431751

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41104913
NACRES:
NB.24

material

Nylon
white

sterility

sterile

packaging

pack of 50 ea
pkg of (individually wrapped)

manufacturer/tradename

Corning 431751

pore size

70 μm

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Corning® 70μm Cell Strainer is a sterile, easy-to-use device for rapidly isolating primary cells to consistently obtain a uniform single-cell suspension from tissues.

Application

Corning® 70μm Cell Strainer is a faster, easier alternative to gauze filtration. It is ideal for preparation of flow cytometry samples, including:
  • Single cell suspensions of blood cells from marrow, pancreas, thymus, tonsil, and lymph nodes
  • Stem cells, tissue-derived cells, and cancer cells
  • Preparation of specimens for primary cell cultures and immunogens
  • Preparation of freezing stocks
  • Filtering agglutinative proteins produced in inactivation serum

Features and Benefits

  • Strong nylon mesh with 70- micron pores for optimal performance in a variety of applications
  • Evenly spaced mesh pores providing consistent and reliable results
  • Conveniently accessible in individual packaging
  • Extended lip on strainer enables aseptic handling with forceps
  • Molded color-coded polypropylene frame with tab enables easy handling and identification
  • Fits all major brands of 50mL conical tubes
  • Disposable, easy-to-use, inexpensive, maintains sample integrity
  • Sterilized by γ−irradiation, noncytotoxic

Legal Information

Corning is a registered trademark of Corning, Inc.

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Lamba Omar Sangaré et al.
Cell host & microbe, 26(4), 478-492 (2019-10-11)
Toxoplasma can reach distant organs, especially the brain, leading to a lifelong chronic phase. However, genes involved in related in vivo processes are currently unknown. Here, we use focused CRISPR libraries to identify Toxoplasma genes that affect in vivo fitness. We focus
José A Jiménez-Torres et al.
EBioMedicine, 42, 408-419 (2019-03-25)
Anti-angiogenic treatment failure is often attributed to drug resistance, unsuccessful drug delivery, and tumor heterogeneity. Recent studies have speculated that anti-angiogenic treatments may fail due to characteristics inherent to tumor-associated blood vessels. Tumor-associated blood vessels are phenotypically different from their
Kelly C Santos Roballo et al.
Biomaterials, 209, 1-9 (2019-04-26)
Segmental injuries to peripheral nerves (PNs) too often result in lifelong disability or pain syndromes due to a lack of restorative treatment options. For injuries beyond a critical size, a bridging device must be inserted to direct regeneration. PN allografts
Cristina Morales Torres et al.
Nature communications, 11(1), 1792-1792 (2020-04-15)
Continuous cancer growth is driven by subsets of self-renewing malignant cells. Targeting of uncontrolled self-renewal through inhibition of stem cell-related signaling pathways has proven challenging. Here, we show that cancer cells can be selectively deprived of self-renewal ability by interfering
Alexandros P Drainas et al.
Cell reports, 31(1), 107465-107465 (2020-04-09)
TP53 deficiency is the most common alteration in cancer; however, this alone is typically insufficient to drive tumorigenesis. To identify genes promoting tumorigenesis in combination with TP53 deficiency, we perform genome-wide CRISPR-Cas9 knockout screens coupled with proliferation and transformation assays
View All Related Papers

Articles

Accelerated Osteocyte Differentiation of Human Mesenchymal Stem Cells in a Novel Xeno-free and Serum-free Osteogenesis Differentiation Media

Development of a novel serum-free and xeno-free human mesenchymal stem cell (MSC) osteocyte differentiation media.

3D Organoid Culture: New In Vitro Models of Development and Disease

Organoid culture products to generate tissue and stem cell derived 3D brain, intestinal, gut, lung and cancer tumor organoid models.

Protocols

Mesenchymal Stem Cell Culture Protocols

Information about mesenchyme, specifically mesenchymal stem cell procotols. Step-by-step cell culture protocols for mesenchymal stem cell (MSC) isolation, expansion and differentiation.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service